Stock Events

Stock Events

Lineage Cell Therapeutics (LCTX) Q2 2026 Earnings

12MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-0.13

-0.09

-0.06

-0.02

Details

Expected EPS

-0.02

Actual EPS

-0.03

Surprise EPS

-0.01

Surprise Percent

+50%

Description

Lineage Cell Therapeutics (LCTX) has reported earnings of -0.03 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.